Researchers at Johns Hopkins All Children’s Hospital developed a groundbreaking approach that transforms “immune-cold” tumors into “immune-hot” environments by simultaneously activating two key immune signaling pathways (STING and LTβR).
Researchers at Johns Hopkins All Children’s Hospital developed a groundbreaking approach that transforms “immune-cold” tumors into “immune-hot” environments by simultaneously activating two key immune signaling pathways (STING and LTβR).
This issue’s cover features work by Victor Nizet & team on the unexpected potent activity of colistin against multidrug-resistant, mcr+, Gram-negative bacterial pathogens, including E. coli and Salmonella enterica: www.jci.org/articles/vie...
This issue’s cover features work by Victor Nizet & team on the unexpected potent activity of colistin against multidrug-resistant, mcr+, Gram-negative bacterial pathogens, including E. coli and Salmonella enterica: www.jci.org/articles/vie...
www.globenewswire.com/news-release...
www.globenewswire.com/news-release...